Follow
Sean Emery
Sean Emery
UNSW Sydney
Verified email at unsw.edu.au
Title
Cited by
Cited by
Year
Initiation of antiretroviral therapy in early asymptomatic HIV Infection
et al. Lundgren JD, Gordin F, Babiker A, Emery S
N Engl J Med 373, 795-807, 2015
3140*2015
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.
RMSSPTES Buchbinder SP, Mehrota DV, Duerr A, Fitzgerald DW, Mogg D, Li P ...
Lancet 2008; 372: 1881-93 (IF=39.207, citations=775)., 2008
1993*2008
Plasma levels of soluble CD14 independently predict mortality in HIV infection
NG Sandler, H Wand, A Roque, M Law, MC Nason, DE Nixon, ...
Journal of Infectious Diseases 203 (6), 780-790, 2011
12752011
HIV-1 vaccine induced immunity in the test of concept Step study: a case-cohort analysis.
CSSE McElrath MJ, DeRosa SC, Moodie Z, Dubey S, Kierstead L, Janes H, Defawe ...
Lancet 2008; 372: 1894-1905 (IF=39.207, citations=400)., 2008
881*2008
Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study
Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of infectious diseases 197 (8), 1133-1144, 2008
5772008
Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study
BR Bavinton, AN Pinto, N Phanuphak, B Grinsztejn, GP Prestage, ...
The lancet HIV 5 (8), e438-e447, 2018
5302018
Interleukin-2 therapy in patients with HIV infection
INSIGHT–ESPRIT Study Group and SILCAAT Scientific Committee
New England Journal of Medicine 361 (16), 1548-1559, 2009
4272009
Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III …
K Samaras, H Wand, M Law, S Emery, D Cooper, A Carr
Diabetes care 30 (1), 113-119, 2007
4152007
Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study
A Martin, DE Smith, A Carr, C Ringland, J Amin, S Emery, J Hoy, ...
Aids 18 (7), 1029-1036, 2004
3722004
Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trial
A Martin, M Bloch, J Amin, D Baker, DA Cooper, S Emery, A Carr, ...
Clinical Infectious Diseases 49 (10), 1591-1601, 2009
3022009
No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial
A Carr, C Workman, D Carey, G Rogers, A Martin, D Baker, H Wand, ...
The Lancet 363 (9407), 429-438, 2004
2872004
Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant …
A Duerr, Y Huang, S Buchbinder, RW Coombs, J Sanchez, C del Rio, ...
The Journal of infectious diseases 206 (2), 258-266, 2012
2802012
HIV lipodystrophy: prevalence, severity and correlates of risk in Australia
J Miller, A Carr, S Emery, M Law, S Mallal, D Baker, D Smith, J Kaldor, ...
HIV medicine 4 (3), 293-301, 2003
2782003
Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV …
Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of infectious diseases 197 (8), 1145-1155, 2008
2592008
Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection
H Wand, A Calmy, DL Carey, K Samaras, A Carr, MG Law, DA Cooper, ...
Aids 21 (18), 2445-2453, 2007
2502007
Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase
JM Murray, S Emery, AD Kelleher, M Law, J Chen, DJ Hazuda, ...
Aids 21 (17), 2315-2321, 2007
2402007
Risk of all-cause mortality associated with non-fatal AIDS and serious non-AIDS events among adults infected with HIV.
SESEEC Neuhaus J, Angus B, Kowalska JD, La Rosa A, Sampson J, Wentworth D ...
AIDS 2010; 24: 697-706 (IF=6.557, citations=70)., 2010
234*2010
Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation
ESGESSSCES Nordell A, McKenna M, Borges AH, Duprez D, Neuhaus J, Neaton JD ...
J Am Heart Assoc 2014; 3: e000844 (IF=2.882, citations=1), 2014
226*2014
In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA
PWG Mallon, P Unemori, R Sedwell, A Morey, M Rafferty, K William, ...
Journal of Infectious Diseases 191 (10), 1686-1696, 2005
2102005
High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40)
JJ Zaunders, ML Munier, N Seddiki, S Pett, S Ip, M Bailey, Y Xu, K Brown, ...
The Journal of Immunology 183 (4), 2827-2836, 2009
1932009
The system can't perform the operation now. Try again later.
Articles 1–20